A Global Life Science Investment Bank
with a Co-founder Mentality
Who We Are
Locust Walk is a global investment bank that partners with founders, executives, and board members to drive strategic transactions and create newcos to finance innovation.
Our 17-year history of success was forged through our Co-founder MentalityTM focused on innovators, our local on the ground presence in Boston, San Francisco, Tokyo, and Beijing, and our deep understanding of how science and data translate into actionable transactions and business strategy.
2008
36
3
Locust Walk Offices
80+
Our Thought Leadership
Core Values
Featured Recent Transactions
Exclusive financial advisor to Prazer Therapeutics in R&D Collaboration with Johnson & Johnson
Exclusive financial advisor to DURECT Corporation in sale to Bausch Health: $63M Upfront + Up to $350M in CVRs
Exclusive financial advisor to Checkpoint Therapeutics in sale to Sun Pharma for up to $416M
Latest News and Events
Align Summit
Sun pharma to acquire checkpoint Therapeutics
Click here for a full summary of the event. Locust Walk co-hosted the third annual Align Summit in Boston, an event organized by MassBio and co-hosted by McKinsey to spotlight emerging biotech innovation and foster meaningful connections across the ecosystem.
Bausch Health to Acquire DURECT Corporation
Bausch Health Companies Inc. (NYSE: BHC) (TSX: BHC), a global, diversified pharmaceutical company, and DURECT Corporation (NASDAQ: DRRX) today announced a definitive agreement under which Bausch Health will indirectly acquire DURECT Corporation, including a novel therapeutic molecule, larsucosterol, which can harness the power of epigenetic modulation.
Build with Us
